Meinten Sie: person:("gazzar, A.")
-
A never-smoker lung adenocarcinoma patient with a MET exon 14 mutation (D1028N) and a rapid partial response after crizotinib
British Library Online Contents | 2016| -
A Phase Ib dose escalation study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours
British Library Conference Proceedings | 2015| -
iTRAQ: a method to elucidate cellular responses to mycotoxin zearalenone
British Library Online Contents | 2013| -
Sequential events of apoptosis induced by zearalenone in cultured hepatocarcinoma cells
British Library Online Contents | 2010| -
Antitumor activity in advanced cancer patients with thymic malignancies enrolled in early clinical drug development programs (Phase I trials) at Gustave Roussy
British Library Online Contents | 2015| -
Patients aged over 75 years enrolled in Phase I clinical trials: the Gustave Roussy experience
British Library Online Contents | 2016| -
O3.5 A Phase Ib dose escalation study of afatinib in combination with standard-dose cetuximab in patients with advanced solid tumours
British Library Online Contents | 2015| -
P1.07 Outcome of patients with relapsed/refractory lymphoma in a large cohort inside a phase 1 clinic department
British Library Online Contents | 2015| -
First case report of intrathecal panitumumab for treatment of meningeal carcinomatousis in an EGFR mutant lung adenocarcinoma patient
British Library Online Contents | 2013| -
Predictive factors of renal toxicities related to anti-VEGFR multikinase inhibitors in phase 1 trials
British Library Online Contents | 2017| -
A phase I, dose-escalation study of the Eg5-inhibitor EMD 534085 in patients with advanced solid tumors or lymphoma
British Library Online Contents | 2013| -
86O Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
British Library Online Contents | 2017| -
Patterns of responses in metastatic NSCLC during PD-1 or PDL-1 inhibitor therapy: Comparison of RECIST 1.1, irRECIST and iRECIST criteria
British Library Online Contents | 2018| -
Phase Ib study of afatinib plus standard-dose cetuximab in patients with advanced solid tumours
British Library Online Contents | 2016| -
3032A Activity and safety profile of lucitanib in patients with advanced thymic epithelial tumours
British Library Online Contents | 2015| -
First-in-human phase I trial of the anti-CEACAM5 antibody–drug conjugate SAR408701 in patients with advanced solid tumors (NCT02187848)
British Library Online Contents | 2016| -
Immunotherapy phase I trials in patients Older than 70 years with advanced solid tumours
British Library Online Contents | 2018|
Meine Suche schicken an (beta)
Schicken Sie ihre Suchanfrage (Suchterm ohne Filter) an andere Datenbanken, Portale und Kataloge, um ggf. weitere interessante Treffer zu finden:
Dimensions ist eine Datenbank für Abstracts und Zitate, die Informationen zu Forschungsförderungen mit daraus resultierenden Veröffentlichungen, Studien und Patenten verknüpft.
Im TIB AV-Portal können audiovisuelle Medien aus Wissenschaft und Lehre recherchiert und eigene wissenschaftliche Videos publiziert werden.
Im FID move kann nach fachspezifischer Literatur, Forschungsdaten und weitere Informationen aus der Mobilitäts- und Verkehrsforschung gesucht werden.
Der Open Research Knowledge Graph liefert strukturiert beschriebene Forschungsinhalte und macht diese vergleichbar.
Frei zugänglicher Ausschnitt der Verbunddatenbank K10plus des GBV und des SWB mit für die Fernleihe und Direktlieferdienste relevanten Materialien.